Harvard Bioscience (HBIO) Long-Term Deferred Tax (2010 - 2019)
Harvard Bioscience (HBIO) posted quarterly Long-Term Deferred Tax of $210000.0 for Q2 2019, up 18.64% year-over-year from $177000.0 in Q2 2018, and up 0.96% quarter-over-quarter from $208000.0 in Q1 2019.
Harvard Bioscience (HBIO) Long-Term Deferred Tax (2010 - 2019) Analysis & Trends
Harvard Bioscience (HBIO) has reported Long-Term Deferred Tax for 10 consecutive years, with $210000.0 the latest figure, recorded in Q2 2019.
- In Q2 2019, Long-Term Deferred Tax rose 18.64% year-over-year to $210000.0; the TTM figure through Jun 2019 stood at $210000.0 (up 18.64% YoY), while the FY2017 annual figure was $182000.0, up 103.46% from the prior year.
- Long-Term Deferred Tax rose to $210000.0 in Q2 2019 per HBIO's latest filing, from $208000.0 in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $11.0 million in Q3 2015 and bottomed at -$5.3 million in Q4 2016.
- Historically, Long-Term Deferred Tax has averaged $2.2 million across 5 years, with a median of $995000.0 in 2015.
- Annual changes were most pronounced in 2016 — Long-Term Deferred Tax slumped 628.64% — and 2017, when it soared 103.46%.
- Harvard Bioscience's Long-Term Deferred Tax stood at $995000.0 in 2015, then plunged by 628.64% to -$5.3 million in 2016, then jumped by 103.46% to $182000.0 in 2017, then fell by 1.65% to $179000.0 in 2018, then grew by 17.32% to $210000.0 in 2019.
- Business Quant data shows HBIO's Long-Term Deferred Tax at $210000.0 in Q2 2019, $208000.0 in Q1 2019, and $179000.0 in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Harvard Bioscience | 33.45 Mn | 26.94 Mn | 12.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 210,000.00 |
| Mar 31, 2019 | 208,000.00 |
| Sep 30, 2018 | 179,000.00 |
| Jun 30, 2018 | 177,000.00 |
| Mar 31, 2018 | 1.10 Mn |
| Dec 31, 2017 | 182,000.00 |
| Sep 30, 2017 | 1.27 Mn |
| Jun 30, 2017 | 1.23 Mn |
| Mar 31, 2017 | 1.18 Mn |
| Dec 31, 2016 | -5.26 Mn |
| Sep 30, 2016 | 931,000.00 |
| Jun 30, 2016 | 954,000.00 |
| Mar 31, 2016 | 1.04 Mn |
| Dec 31, 2015 | 995,000.00 |
| Sep 30, 2015 | 11.05 Mn |
| Jun 30, 2015 | 11.02 Mn |
| Mar 31, 2015 | 10.95 Mn |
| Dec 31, 2014 | 17.56 Mn |
| Sep 30, 2014 | 12.77 Mn |
| Jun 30, 2014 | 13.01 Mn |